ARCH Venture Partners XII, LLC

Average Profitability
3.29%
Insider Buys Quantity
15
Insider Buys Sum
$25.93M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of ARCH Venture Partners XII, LLC

According to the SEC Form 4 filings, ARCH Venture Partners XII, LLC, being in a position of

  1. 10 percent owner at Prime Medicine, Inc.,
    оver the last 12 months, has bought 3200000 shares for $20M, and sold 0 shares,
    over all time since 2024-02-15, has bought 3200000 shares for $20M, and sold 0 shares.

The largest purchase of all time was on 2024-02-15 and amounted to 3200000 shares of Prime Medicine, Inc. for $20M.

Biography of ARCH Venture Partners XII, LLC

No biography is available at this moment.

2024-02-15PurchasePrime Medicine, Inc.
PRME
10 percent owner
3.2M
4.6348%
$6.25$20M-36.86%
2023-11-14PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
3,357
0.0025%
$11.98$40,217+3.37%
2023-11-13PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
31,653
0.0232%
$11.75$371,923+2.51%
2023-11-10PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
17,275
0.0124%
$11.49$198,481+5.87%
2023-11-09PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
31,079
0.0204%
$10.53$327,262+15.57%
2023-11-08PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
92,251
0.0634%
$11.03$1.02M+15.05%
2023-11-07PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
30,192
0.0216%
$11.50$347,208+5.26%
2023-11-06PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
43,082
0.031%
$11.55$497,597+6.66%
2023-11-03PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
22,420
0.0159%
$11.38$255,140+2.7%
2023-09-29PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
34,560
0.0301%
$13.98$483,149-15.59%
2023-09-28PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
41,951
0.0351%
$13.44$563,699-9.91%
2023-09-27PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
24,504
0.0188%
$12.31$301,644+0.76%
2023-09-26PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
34,000
0.0248%
$11.73$398,820+1.71%
2023-09-25PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
60,740
0.0424%
$11.22$681,464+4.43%
2023-09-22PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
40,000
0.0277%
$11.14$445,600+7.62%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.